or Try an Advanced Search...

    Technical Analysis for NTRB - Nutriband Inc.

    Grade Last Price % Change Price Change
    B 5.99 10.93% 0.59
    NTRB closed up 10.93 percent on Monday, July 1, 2024, on approximately normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical NTRB trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
    Outside Day Range Expansion 0.00%
    20 DMA Resistance Bearish 10.93%
    Doji - Bearish? Reversal 10.93%
    Outside Day Range Expansion 10.93%
    20 DMA Resistance Bearish 12.17%
    Inside Day Range Contraction 12.17%
    Gapped Up Strength 12.17%
    Older End-of-Day Signals for NTRB ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 20 DMA about 9 hours ago
    10 DMA Support about 9 hours ago
    Rose Above Previous Day's High about 9 hours ago
    Outside Day about 9 hours ago
    Up 5% about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    NTRB Chart by TradingView
    Basic chart:

    Profile

    The Company is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Its lead product under development is its abuse deterrent fentanyl transdermal system which the Company is developing to provide clinicians and patients with an abuse deterrent transdermal fentanyl product for use in managing chronic pain requiring opioid therapy. The product is combined with properties designed to help combat the opioid crisis by deterring the abuse and misuse of fentanyl patches
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Euphoriants Chronic Pain Opioids Analgesics Heroin Morphine Fentanyl Anilides

    Is NTRB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 20 Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl
    Jun 3 Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year
    May 21 Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on May 30
    May 16 Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors
    May 10 Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Apr 25 IBN Coverage Initiated for Nutriband Inc.
    Apr 24 Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission
    Apr 23 Nutriband signs exclusive supplier agreement with Fit for Life
    Apr 23 Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group
    Mar 27 Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch
    See more NTRB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.75
    52 Week Low 1.53
    Average Volume 32,373
    200-Day Moving Average 3.19
    50-Day Moving Average 4.69
    20-Day Moving Average 5.55
    10-Day Moving Average 5.44
    Average True Range 0.53
    RSI (14) 59.84
    ADX 40.72
    +DI 27.06
    -DI 11.37
    Chandelier Exit (Long, 3 ATRs) 5.16
    Chandelier Exit (Short, 3 ATRs) 6.29
    Upper Bollinger Bands 6.22
    Lower Bollinger Band 4.88
    Percent B (%b) 0.83
    BandWidth 24.15
    MACD Line 0.20
    MACD Signal Line 0.24
    MACD Histogram -0.0409
    Fundamentals Value
    Market Cap 50.67 Million
    Num Shares 8.46 Million
    EPS -0.67
    Price-to-Earnings (P/E) Ratio -8.94
    Price-to-Sales 10.45
    Price-to-Book 3.72
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 7.10
    Resistance 3 (R3) 6.98 6.49 6.92
    Resistance 2 (R2) 6.49 6.20 6.55 6.86
    Resistance 1 (R1) 6.24 6.03 6.36 6.36 6.79
    Pivot Point 5.74 5.74 5.80 5.80 5.74
    Support 1 (S1) 5.49 5.46 5.62 5.62 5.19
    Support 2 (S2) 5.00 5.28 5.06 5.12
    Support 3 (S3) 4.75 5.00 5.06
    Support 4 (S4) 4.88